Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 1
2014 2
2018 1
2020 5
2021 5
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Coronavirus Disease (COVID-19): Challenges and Opportunities.
Farnoosh G, Alishiri G, Jalali Farahani A, Javidi N, Farhangi Z, Bahadori M, Ravangard R. Farnoosh G, et al. Among authors: alishiri g. Disaster Med Public Health Prep. 2022 Apr;16(2):431-433. doi: 10.1017/dmp.2020.341. Epub 2020 Sep 10. Disaster Med Public Health Prep. 2022. PMID: 32907671 Free PMC article. No abstract available.
Ozone therapy for the treatment of COVID-19 pneumonia: A scoping review.
Izadi M, Cegolon L, Javanbakht M, Sarafzadeh A, Abolghasemi H, Alishiri G, Zhao S, Einollahi B, Kashaki M, Jonaidi-Jafari N, Asadi M, Jafari R, Fathi S, Nikoueinejad H, Ebrahimi M, Imanizadeh S, Ghazale AH. Izadi M, et al. Among authors: alishiri g. Int Immunopharmacol. 2021 Mar;92:107307. doi: 10.1016/j.intimp.2020.107307. Epub 2020 Dec 21. Int Immunopharmacol. 2021. PMID: 33476982 Free PMC article. Review.
Melatonin as a complementary and prophylactic agent against COVID-19 in high-risk populations: A narrative review of recent findings from clinical and preclinical studies.
Hosseini A, Badri T, Esmaeili Gouvarchin Ghaleh H, Hassanpour K, Alishiri G, Akbariqomi M, Farnoosh G. Hosseini A, et al. Among authors: alishiri g. Fundam Clin Pharmacol. 2022 Dec;36(6):918-929. doi: 10.1111/fcp.12805. Epub 2022 May 31. Fundam Clin Pharmacol. 2022. PMID: 35567287 Review.
Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial.
Farnoosh G, Akbariqomi M, Badri T, Bagheri M, Izadi M, Saeedi-Boroujeni A, Rezaie E, Ghaleh HEG, Aghamollaei H, Fasihi-Ramandi M, Hassanpour K, Alishiri G. Farnoosh G, et al. Among authors: alishiri g. Arch Med Res. 2022 Jan;53(1):79-85. doi: 10.1016/j.arcmed.2021.06.006. Epub 2021 Jun 23. Arch Med Res. 2022. PMID: 34229896 Free PMC article. Clinical Trial.
NLRP3 inflammasome activation and oxidative stress status in the mild and moderate SARS-CoV-2 infected patients: impact of melatonin as a medicinal supplement.
Esmaeili Gouvarchin Ghaleh H, Hosseini A, Aghamollaei H, Fasihi-Ramandi M, Alishiri G, Saeedi-Boroujeni A, Hassanpour K, Mahmoudian-Sani MR, Farnoosh G. Esmaeili Gouvarchin Ghaleh H, et al. Among authors: alishiri g. Z Naturforsch C J Biosci. 2021 Aug 6;77(1-2):37-42. doi: 10.1515/znc-2021-0101. Print 2022 Jan 27. Z Naturforsch C J Biosci. 2021. PMID: 34355546
Cytokine profile and antioxidants status in the moderate and severe COVID-19 patients: a trial of ozone therapy impact as a medicinal supplement.
Ghaleh HEG, Izadi M, Javanbakht M, Ghanei M, Einollahi B, Jafari NJ, Alishiri G, Aslani J, Abolghasemi H, Simonetti V, Khafaei M, Zhao S, Saadat SH, Ahmadi M, Parvin S, Vazifedoust S, Alvanagh AG. Ghaleh HEG, et al. Among authors: alishiri g. Inflammopharmacology. 2023 Dec;31(6):3029-3036. doi: 10.1007/s10787-023-01288-9. Epub 2023 Jul 12. Inflammopharmacology. 2023. PMID: 37436523
Safety and immunogenicity of a recombinant receptor-binding domain-based protein subunit vaccine (Noora vaccine™) against COVID-19 in adults: A randomized, double-blind, placebo-controlled, Phase 1 trial.
Salimian J, Ahmadi A, Amani J, Olad G, Halabian R, Saffaei A, Arabfard M, Nasiri M, Nazarian S, Abolghasemi H, Alishiri G. Salimian J, et al. Among authors: alishiri g. J Med Virol. 2023 Feb;95(2):10.1002/jmv.28097. doi: 10.1002/jmv.28097. Epub 2022 Sep 13. J Med Virol. 2023. PMID: 36029105 Free PMC article. Retracted. Clinical Trial.
17 results